Shinzato T, Nakai S, Akiba T, Yamagami S, Yamazaki C, Kitaoka T, Kubo K, Maeda K, Morii H
Japanese Society for Dialysis Therapy, Nagoya University Daiko Medical Center, Japan.
Kidney Int. 1999 Feb;55(2):700-12. doi: 10.1046/j.1523-1755.1999.00297.x.
Nearly 170,000 patients were treated by maintenance renal replacement therapy (RRT) in Japan in 1996. The current status of Japanese patients on RRT might, in some way, be suggestive for patients on RRT in other countries.
The Japanese Society for Dialysis Therapy conducts a questionnaire survey of virtually every dialysis facility in Japan at the end of each year. Here we present the results of our survey of patients undergoing RRT as of the end of 1996, as well as five-year trends (1992-1996) in some of the data.
The response rate was 99.8%. At the end of 1996, there were 167,192 patients on maintenance RRT in Japan (1,328 persons per million population). The numbers of patients on maintenance RRT continued to increase during the five-year period. The gross mortality rate for that period ranged from 9.4% to 9.7%. Cuprammonium rayon was the most commonly used material (24.0%) for dialyzer membranes, followed by cellulose triacetate (18.7%). Approximately 5.0% of hemodialysis (HD) patients had a prior history of surgical release of carpal tunnel. The longer the years on HD therapy, the greater the proportion of patients with a history of such an operation. The predialysis plasma beta 2-microglobulin concentration was highest in patients aged 30 to 45 years and declined slightly after the age of 45. There was no significant difference in the HbA1c level between continuous ambulatory peritoneal dialysis and HD patients, both in whom diabetes was the disease causing renal failure. Moreover, among HD patients with diabetes, there was a clear tendency for the HbA1c level to be higher when the normalized protein catabolic rate was higher.
This report summarizes the latest results of the survey on Japanese patients on RRT.
1996年，日本有近17万名患者接受维持性肾脏替代治疗（RRT）。日本接受RRT治疗患者的现状可能在某种程度上对其他国家接受RRT治疗的患者具有启示意义。
日本透析治疗学会每年年底对日本几乎所有透析机构进行问卷调查。在此，我们展示截至1996年底接受RRT治疗患者的调查结果，以及部分数据的五年趋势（1992 - 1996年）。
回复率为99.8%。1996年底，日本有167,192名维持性RRT患者（每百万人口中有1328人）。在这五年期间，维持性RRT患者数量持续增加。该期间的总死亡率在9.4%至9.7%之间。铜氨人造丝是透析器膜最常用的材料（24.0%），其次是三醋酸纤维素（18.7%）。约5.0%的血液透析（HD）患者有腕管手术松解史。HD治疗时间越长，有此类手术史的患者比例越高。透析前血浆β2 -微球蛋白浓度在30至45岁患者中最高，45岁以后略有下降。在因糖尿病导致肾衰竭的持续非卧床腹膜透析患者和HD患者中，糖化血红蛋白（HbA1c）水平无显著差异。此外，在患有糖尿病的HD患者中，当标准化蛋白分解代谢率较高时，HbA1c水平有明显升高的趋势。
本报告总结了对日本接受RRT治疗患者调查的最新结果。
